-
1
-
-
51349090473
-
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
-
Hacein-Bey-Abina S, Garrigue A, Wang GP, et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008;118(9):3132-3142.
-
(2008)
J Clin Invest
, vol.118
, Issue.9
, pp. 3132-3142
-
-
Hacein-Bey-Abina, S.1
Garrigue, A.2
Wang, G.P.3
-
2
-
-
51349158298
-
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
-
Howe SJ, Mansour MR, Schwarzwaelder K, et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest. 2008;118(9):3143-50.
-
(2008)
J Clin Invest
, vol.118
, Issue.9
, pp. 3143-3150
-
-
Howe, S.J.1
Mansour, M.R.2
Schwarzwaelder, K.3
-
3
-
-
0025759278
-
The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13
-
Boehm T, Foroni L, Kaneko Y, et al. The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl. Acad. Sci. 1991;88:4367-4371.
-
(1991)
Proc. Natl. Acad. Sci
, vol.88
, pp. 4367-4371
-
-
Boehm, T.1
Foroni, L.2
Kaneko, Y.3
-
4
-
-
0025933456
-
TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukemia with the t(11;14) (p13;q11)
-
Royer-Pokora B, Loos U, and Ludwig WD. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukemia with the t(11;14) (p13;q11). Oncogene. 1991;6:1887-1893.
-
(1991)
Oncogene
, vol.6
, pp. 1887-1893
-
-
Royer-Pokora, B.1
Loos, U.2
Ludwig, W.D.3
-
5
-
-
33646875083
-
Retrovirus Vectors: Toward the Plentivirus?
-
Baum C, Schambach A, Bohne J, and Galla M. Retrovirus Vectors: Toward the Plentivirus? Mol Ther. 2006;13:1050-1063.
-
(2006)
Mol Ther
, vol.13
, pp. 1050-1063
-
-
Baum, C.1
Schambach, A.2
Bohne, J.3
Galla, M.4
-
6
-
-
0037841763
-
Transcription start regions in the human genome are favored targets for MLV integration
-
Wu X, Li Y, Crise B, and Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science. 2003;300(5626):1749-1751.
-
(2003)
Science
, vol.300
, Issue.5626
, pp. 1749-1751
-
-
Wu, X.1
Li, Y.2
Crise, B.3
Burgess, S.M.4
-
7
-
-
34147224008
-
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
-
Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446:758-764.
-
(2007)
Nature
, vol.446
, pp. 758-764
-
-
Mullighan, C.G.1
Goorha, S.2
Radtke, I.3
-
8
-
-
33750624015
-
Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity
-
Modlich U, Bohne J, Schmidt M, et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood. 2006;108:2545-2553.
-
(2006)
Blood
, vol.108
, pp. 2545-2553
-
-
Modlich, U.1
Bohne, J.2
Schmidt, M.3
-
9
-
-
41149133413
-
Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors
-
Zychlinski D, Schambach A, Modlich U, et al. Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors. Mol Ther. 2008;16(4):718-725.
-
(2008)
Mol Ther
, vol.16
, Issue.4
, pp. 718-725
-
-
Zychlinski, D.1
Schambach, A.2
Modlich, U.3
-
10
-
-
0037105522
-
Development of virus vectors for gene therapy of beta chain hemoglobinopathies: Flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo
-
Emery DW, Yannaki E, Tubb J, et al. Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo. Blood. 2002;100:2012-2019.
-
(2002)
Blood
, vol.100
, pp. 2012-2019
-
-
Emery, D.W.1
Yannaki, E.2
Tubb, J.3
-
11
-
-
15244346492
-
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells
-
De Palma M, Montini E, Santoni de Sio FR, et al. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood.2005;105(6):2307-15.
-
(2005)
Blood
, vol.105
, Issue.6
, pp. 2307-2315
-
-
de Palma, M.1
Montini, E.2
de Santoni Sio, F.R.3
-
12
-
-
0031897966
-
A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences
-
Chong H, Starkey W, and Vile RG. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J Virol.1998;72:2663-2670.
-
(1998)
J Virol
, vol.72
, pp. 2663-2670
-
-
Chong, H.1
Starkey, W.2
Vile, R.G.3
-
13
-
-
18044401735
-
Gene therapy. Viral vectors still pack surprises
-
Marshall E. Gene therapy. Viral vectors still pack surprises. Science. 2001;294(5547):1640.
-
(2001)
Science
, vol.294
, Issue.5547
, pp. 1640
-
-
Marshall, E.1
-
14
-
-
33644820684
-
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
-
Manno CS, Pierce GF, Arruda VR, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12(3):342-7.
-
(2006)
Nat Med
, vol.12
, Issue.3
, pp. 342-347
-
-
Manno, C.S.1
Pierce, G.F.2
Arruda, V.R.3
-
15
-
-
84855228836
-
-
3. Notification ("3. Bekanntmachung") of the Federal Institute for Drugs and Medical Devices and the Paul Ehrlich Institute of 10 August, on the clinical trial of medicinal products for human use
-
3. Notification ("3. Bekanntmachung") of the Federal Institute for Drugs and Medical Devices and the Paul Ehrlich Institute of 10 August 2006 on the clinical trial of medicinal products for human use.
-
, vol.2006
-
-
-
16
-
-
84855219932
-
-
Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use
-
Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use. OJ L 159, 27.06.2006, p.46.
-
(2006)
OJ L
, vol.159
, pp. 46
-
-
-
17
-
-
84855233693
-
-
Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use
-
Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. OJ L 262, 14.10.2003, p.22.
-
(2003)
OJ L
, vol.262
, pp. 22
-
-
-
18
-
-
4043127889
-
-
Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components
-
Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. OJ L 91, 30.03.2004, p.25.
-
(2004)
OJ L
, vol.91
, pp. 25
-
-
-
19
-
-
84855218572
-
-
Commission Directive 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards traceability requirements and notification of serious adverse reactions and events
-
Commission Directive 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards traceability requirements and notification of serious adverse reactions and events. OJ L 256, 01.10.2005, p.32.
-
(2005)
OJ L
, vol.256
, pp. 32
-
-
-
20
-
-
84855219931
-
-
Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments
-
Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments. OJ L 256, 01.10.2005, p.41.
-
(2005)
OJ L
, vol.256
, pp. 41
-
-
-
21
-
-
33750505712
-
-
Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells
-
Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. OJ L 38, 09.02.2006, p.40.
-
(2006)
OJ L
, vol.38
, pp. 40
-
-
-
22
-
-
0142044886
-
-
Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices
-
Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices. OJ L 189, 20.07.1990, p.17
-
(1990)
OJ L
, vol.189
, pp. 17
-
-
-
23
-
-
0003184979
-
-
Council Directive 93/42/EEC of 14 June 1993 concerning medical devices
-
Council Directive 93/42/EEC of 14 June 1993 concerning medical devices. OJ L 169, 12.07.1993, p.1.
-
(1993)
OJ L
, vol.169
, pp. 1
-
-
-
24
-
-
73449145464
-
-
CHMP/BWP/2458/03 of the Committee for Medicinal Products for Human Use (CHMP) of 26 May
-
CHMP/BWP/2458/03 of the Committee for Medicinal Products for Human Use (CHMP) of 26 May 2005. Guideline on development and manufacture of lentiviral vectors.
-
(2005)
Guideline On Development and Manufacture of Lentiviral Vectors
-
-
-
26
-
-
84855229523
-
-
CPMP/ICH/174/95 ICH Topic S 2 B of March, Step 5. Note for guidance on genotoxicity: A standard battery for genotoxicity testing of pharmaceuticals
-
CPMP/ICH/174/95 ICH Topic S 2 B of March 1998. Genotoxicity: A standard battery for genotoxicity testing of pharmaceuticals, Step 5. Note for guidance on genotoxicity: A standard battery for genotoxicity testing of pharmaceuticals.
-
(1998)
Genotoxicity: A Standard Battery For Genotoxicity Testing of Pharmaceuticals
-
-
-
27
-
-
84866740779
-
-
CPMP/ICH/291/95 ICH Topic E 8 of March, step 5. Note for guidance on general considerations for clinical trials
-
CPMP/ICH/291/95 ICH Topic E 8 of March 1998. General considerations for clinical trials, step 5. Note for guidance on general considerations for clinical trials.
-
(1998)
General Considerations For Clinical Trials
-
-
-
28
-
-
0003177157
-
-
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
-
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. OJ L 121, 1.5.2001, p.34.
-
(2001)
OJ L
, vol.121
, pp. 34
-
-
-
29
-
-
0012111484
-
-
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
-
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. OJ L 311, 28.11.2001, p.67.
-
(2001)
OJ L
, vol.311
, pp. 67
-
-
-
30
-
-
84855240353
-
Testing, processing, storage and distribution of human blood and blood componentsand amending Directive 2001/83/EC
-
Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection
-
Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood componentsand amending Directive 2001/83/EC. OJ L 33, 08.02.2003, p.30.
-
(2003)
OJ L
, vol.33
, pp. 30
-
-
-
31
-
-
22044451300
-
Procurement, testing, processing, preservation, storage and distribution of human tissues and cells
-
Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation
-
Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. OJ L 102, 07.04.2004, p.48.
-
(2004)
OJ L
, vol.102
, pp. 48
-
-
-
32
-
-
84855216210
-
-
Directive 2007/47/EC of the European Parliament and of the Council of 5 September, amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/ EC concerning the placing of biocidal products on the market
-
Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/ EC concerning the placing of biocidal products on the market.
-
(2007)
-
-
-
35
-
-
78149270789
-
-
EMEA/CHMP/410869/06 of the Committee for Medicinal Products for Human Use (CHMP) of 21 May
-
EMEA/CHMP/410869/06 of the Committee for Medicinal Products for Human Use (CHMP) of 21 May 2008. Guideline on human cell-based medicinal products.
-
(2008)
Guideline On Human Cell-based Medicinal Products
-
-
-
36
-
-
84855251716
-
-
EMEA/CHMP/BWP/135148/04 of the Committee for Medicinal Products for Human Use (CHMP) of 20, or consisting of, genetically modified organisms (GMOs) (Module 1.6.2)
-
EMEA/CHMP/BWP/135148/04 of the Committee for Medicinal Products for Human Use (CHMP) of 20 January 2005. Environmental risk assessments for medicinal products containing, or consisting of, genetically modified organisms (GMOs) (Module 1.6.2).
-
(2005)
Environmental Risk Assessments For Medicinal Products Containing
-
-
-
37
-
-
34248231583
-
-
EMEA/CHMP/BWP/473191/06-Corr of the Committee for Medicinal Products for Human Use (CHMP) of 11 December, of, or containing, genetically modified organisms (GMOs)
-
EMEA/CHMP/BWP/473191/06-Corr of the Committee for Medicinal Products for Human Use (CHMP) of 11 December 2006. Guideline on environmental risk assessments for medicinal products consisting of, or containing, genetically modified organisms (GMOs).
-
(2006)
Guideline On Environmental Risk Assessments For Medicinal Products Consisting
-
-
-
40
-
-
84855253253
-
-
EMEA/CHMP/GTWP/405681/06 of the Committee for Medicinal Products for Human Use (CHMP) of 24 May, preclinical and clinical aspects of medicinal products containing genetically modified cells
-
EMEA/CHMP/GTWP/405681/06 of the Committee for Medicinal Products for Human Use (CHMP) of 24 May 2007. Concept paper on the development of a guideline on the quality, preclinical and clinical aspects of medicinal products containing genetically modified cells.
-
(2007)
Concept Paper On the Development of a Guideline On the Quality
-
-
-
42
-
-
84855228835
-
-
Eudralex Volume 4. Good manufacturing practice guidelines
-
Eudralex Volume 4. Good manufacturing practice guidelines. Volume 4 of "The rules governing medicinal products in the European Union". http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol4_en.htm
-
The Rules Governing Medicinal Products In the European Union
, vol.4
-
-
-
44
-
-
84855223549
-
-
GCP Ordinance ("GCP-Verordnung"). Of the German Federal Ministry for Health and Social Security of 09 August, for good clinical practice in the conduct of clinical trials on medicinal products for human use
-
GCP Ordinance ("GCP-Verordnung"). Of the German Federal Ministry for Health and Social Security of 09 August 2004 for good clinical practice in the conduct of clinical trials on medicinal products for human use. Federal Law Gazette I, 12.08.2004, p.2081.
-
(2004)
Federal Law Gazette I
, pp. 2081
-
-
-
45
-
-
84855216209
-
-
German Act on Medical Devices ("Medizinproduktegesetz") of the Federal Republic of Germany of 02.08, in the version of the notification of the Law of 07.08. 2002
-
German Act on Medical Devices ("Medizinproduktegesetz") of the Federal Republic of Germany of 02.08.1994 in the version of the notification of the Law of 07.08. 2002. Federal Law Gazette I p.3146.
-
(1994)
Federal Law Gazette I
, pp. 3146
-
-
-
46
-
-
84855239406
-
-
German Tissue Act ("Gewebegesetz") of the German Federal Parliament of 20 July 2007 on the quality and safety of human tissues and cells
-
German Tissue Act ("Gewebegesetz") of the German Federal Parliament of 20 July 2007 on the quality and safety of human tissues and cells. Federal Law Gazette I, 27.07.2007, p.1574.
-
(2007)
Federal Law Gazette I
, pp. 1574
-
-
-
47
-
-
84855216208
-
-
ICH Considerations of the International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use of 25 October
-
ICH Considerations of the International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use of 25 October 2006. General principles to address the risk of inadvertent germline integration of gene therapy vectors.
-
(2006)
General Principles to Address the Risk of Inadvertent Germline Integration of Gene Therapy Vectors
-
-
-
48
-
-
84855219934
-
-
Medicinal Products Act ("Arzneimittelgesetz") of the Federal Republic of Germany of 24.08.1976 in the version of the notification of the Law of 12th December 2005
-
Medicinal Products Act ("Arzneimittelgesetz") of the Federal Republic of Germany of 24.08.1976 in the version of the notification of the Law of 12th December 2005. Federal Law Gazette I p.3394.
-
Federal Law Gazette I
, pp. 3394
-
-
-
49
-
-
84855248994
-
Agriculture and Consumer Protection of 03 November 2006
-
Ordinance for the manufacture of medicinal products and active pharmaceutical ingredients ("AMWHV") of the German Federal Ministries for Health and Food
-
Ordinance for the manufacture of medicinal products and active pharmaceutical ingredients ("AMWHV") of the German Federal Ministries for Health and Food, Agriculture and Consumer Protection of 03 November 2006. Federal Law Gazette I, 09.11.2006, p.2523.
-
(2006)
Federal Law Gazette I
, pp. 2523
-
-
-
50
-
-
77958499413
-
-
Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004
-
Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. OJ L 324, 10.12.2007, p.121.
-
(2007)
OJ L
, vol.324
, pp. 121
-
-
-
51
-
-
84855228837
-
-
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency
-
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. OJ L 136, 30.04.2004, p.1.
-
(2004)
OJ L 136, 30
, vol.4
, pp. 1
-
-
-
52
-
-
84855219933
-
-
Transfusion Law ("Transfusionsgesetz") of the Federal Republic of Germany of 01.07.1998 in the version of the notification of the Law of 28.08.2007
-
Transfusion Law ("Transfusionsgesetz") of the Federal Republic of Germany of 01.07.1998 in the version of the notification of the Law of 28.08.2007. Federal Law Gazette I p.2169
-
Federal Law Gazette I
, pp. 2169
-
-
|